Atlas Trials

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

Clinical trial NCT07322965 · RECRUITING

Trial details

NCT number
NCT07322965
Sponsor
Institut Catala de Retina
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
GlaucomaPrimary Open Angle Glaucoma (POAG)Neuroprotection
Start date
2025-04-01
Primary completion
2027-04-30
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.